Thyroid Gland and Pituitary Gland Histologic Changes Accompanying Sulfamethoxazole-Induced Hypothyroidism in Dogs
ACVIM 2008
A. Gal; T.K. Graves; T. Keel; K.L. Campbell
University of Illinois College of Veterinary Medicine
Urbana, IL, USA

Archived, thyroid and pituitary biopsies from dogs with sulfamethoxazole (SMZ)-induced hypothyroidism were examined for changes in histologic morphology. Dogs were treated alternately with SMZ (30 mg/kg BID) and placebo for 6-week periods in a crossover design.

Random fields were examined on thyroid sections under microscopy. Morphometric analysis was done using MetaMorph® software. Relative proportions of follicular epithelial cells compared with colloid-filled lumina were estimated by subtracting cumulative cross-sectional area of colloid-filled follicles from total area of each field. In pituitary samples, thyrotrophs were detected by immunohistochemical staining, using an anti-canine TSH antibody. TSH-positive pituitary cells were counted in 6 random fields on each slide.

Colloid-containing follicles were markedly smaller and numbers of epithelial cells were greater in dogs following SMZ (N= 6) vs. placebo (N= 6). The median and interquartile range (IQR) of the percentage of thyroid tissue populated by epithelial cells in SMZ-treated dogs was 77.9 (IQR 64.5-91.3) vs. 32.0 (IQR 24.9-39.1) in placebo-treated dogs. The difference between the groups was significant (P = 0.014). SMZ-induced changes were reversed following 6 weeks of placebo. The median number of TSH-positive pituitary cells per field was significantly greater (P < 0.001) on biopsies from SMZ-treated (median 28.5; IQR 12.5-44.5; N = 3) vs. placebo-treated dogs (median 5.0; IQR 0.0-12.25; N = 3).

Our results demonstrate that SMZ-induced hypothyroidism is characterized by reversible thyroid follicular epithelial hyperplasia and colloid collapse. An increased population of pituitary thyrotrophs in SMZ-treated dogs supports recent reports of transdifferentiation of pituitary cells in response to hormonal needs.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Arnon Gal


MAIN : SA Endocrinology : Hypothyroidism
Powered By VIN
SAID=27